2016 Janssen U.S. Transparency Report
The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.
The company just released its second-annual report and we’re spotlighting the top takeaways for patients, consumers and healthcare professionals, including a look at how Janssen approaches drug pricing.
Group Worldwide Chair Sandi Peterson and Company Group Chairman, Pharmaceuticals, The Americas Jennifer Taubert are honorees once again this year.
Jennifer Taubert, Company Group Chairman, Pharmaceuticals, The Americas, explains why Janssen is sharing information around its medication pricing and other business practices.